Skip to main content

Table 1 Dysregulated miRNAs (FC ≤ 0.50 or FC ≥ 2.00, P < 1.92E-04; N = 39) in ESCCa,b

From: Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis

 No.miRNANo.cases expressing miRNAMedian FCP-valueFrequency distribution of cases by FC category
     FC ≤ 0.500.50 < FC < 2.00FC ≥ 2.00
Down-regulated1hsa-miR-375900.029.38E-130.820.110.07
 2hsa-miR-139-5p1120.147.30E-170.810.130.05
 3hsa-miR-133a1130.191.18E-120.700.190.12
 4hsa-miR-133b1110.201.52E-100.630.210.16
 5hsa-miR-885-5p860.272.26E-080.590.300.10
 6hsa-miR-1451120.291.04E-100.630.240.12
 7hsa-miR-486-5p1120.294.13E-100.700.160.14
 8hsa-miR-204990.307.02E-080.620.230.15
 9hsa-miR-2031070.311.11E-040.580.230.19
 10hsa-miR-30a*1130.316.96E-140.650.280.07
 11hsa-miR-378*1040.341.05E-090.620.280.11
 12hsa-let-7c1130.361.58E-090.630.240.13
 13hsa-miR-23b1120.364.80E-110.590.320.09
 14hsa-miR-125b1120.377.66E-090.540.320.13
 15hsa-miR-422a1130.394.39E-100.580.310.12
 16hsa-miR-1491130.402.64E-080.560.320.12
 17hsa-miR-26b*840.404.10E-070.600.270.13
 18hsa-miR-30e*1130.401.88E-110.570.350.09
 19hsa-miR-99a*1110.401.08E-070.590.240.16
 20hsa-miR-3281080.411.07E-090.590.310.10
 21hsa-miR-140-3p1130.442.89E-110.570.360.07
 22hsa-miR-574–3p1120.459.99E-100.530.380.09
 23hsa-miR-1431130.481.63E-070.510.350.13
 24hsa-miR-3781130.481.05E-090.510.380.11
 25hsa-miR-1001130.496.58E-070.500.390.11
 26hsa-miR-1501130.491.64E-110.500.440.05
 27hsa-miR-423-5p1030.491.87E-040.500.290.20
 28hsa-miR-951120.501.17E-060.500.380.12
Up-regulated29hsa-miR-183*902.148.10E-070.120.330.54
 30hsa-miR-106b1092.243.62E-080.100.390.51
 31hsa-miR-7081102.293.46E-090.110.350.55
 32hsa-miR-22982.394.77E-060.180.260.56
 33hsa-miR-639832.441.30E-050.140.300.55
 34hsa-miR-21*1102.693.64E-100.120.290.59
 35hsa-miR-596942.726.48E-060.170.270.56
 36hsa-miR-130b942.782.72E-080.110.310.59
 37hsa-miR-1241002.987.20E-050.210.230.56
 38hsa-miR-211124.600.00E+ 000.020.210.78
 39hsa-miR-196b1049.312.22E-160.060.110.84
  1. amiRs sorted by ascending tumor/normal median fold change (FC)
  2. bP-value threshold for multiple comparison adjustment is P < 1.92E-04 (0.05/260)